A study revealed that excessive glucose uptake by tumor cells restricts the anti-cancer activity of tumor-infiltrating T cells, which leads to increased glycolytic capacity, dampened the mechanistic target of rapamycin kinase (mTOR) activity, and allows tumor progression (Chang et al., 2015). This evidence concerns the gene MTOR and cancer.